Objective To investigate the effective components and therapeutic mechanism of Chaihu-Guizhi-Ganjiang decoction in treating chronic non-atrophic gastritis. Methods The primary and secondary ion fragments of chemical components of Chaihu-Guizhi-Ganjiang decoction were obtained by UHPLC-Q-TOF/MS. Comparing with reference standards and literature information, a comprehensive characterization of the chemical constituents of Chaihu-Guizhi-Ganjiang decoction was conducted. Then, the network pharmacology approach was applied to explore the therapeutic mechanism of Chaihu-Guizhi-Ganjiang decoction in treatment of chronic non-atrophic gastritis based on the components in plasma and verified by immunohistochemical results. Results A total of 24 absorbed components of Chaihu-Guizhi-Ganjiang decoction were characterized, including 11 flavonoid glycosides, 3 fatty acids, 3organic acids, 2 gingerols, 2 flavonoids and, 1 each of fatty aldehydes, triterpenoids and amino acids, which mainly acted on TNF-α, IL-6, STAT3, and PTGS2. It exerted therapeutic effects by modulating signaling pathways, including the IL-17 signaling pathway and the AGE-RAGE signaling pathway, etc. Conclusion This study provided the first exploration of the effective components and therapeutic mechanism of Chaihu-Guizhi-Ganjiang decoction in treatment of chronic non-atrophic gastritis by UHPLC-Q-TOF/MS, which could offer scientific references for its further research.

The emerging paradigm of tumor microecology has reshaped our understanding of carcinogenesis. Colorectal cancer（CRC），a prevalent malignancy worldwide，is not only associated with gut microbial dysbiosis but is also linked to the oral microbiome. Notably， Fusobacterium nucleatum（Fn）can translocate from the oral cavity to the colon via cross-organ migration，colonize tumor tissues，and promote CRC initiation，progression，and therapeutic resistance. This review synthesizes evidence on the association between Fn and CRC，focusing on its promise as a biomarker for early detection，risk stratification，and disease monitoring，to provide novel insights for developing Fn-based strategies for the prevention，diagnosis，and management of CRC.

The emerging paradigm of tumor microecology has reshaped our understanding of carcinogenesis. Colorectal cancer（CRC），a prevalent malignancy worldwide，is not only associated with gut microbial dysbiosis but is also linked to the oral microbiome. Notably， Fusobacterium nucleatum（Fn）can translocate from the oral cavity to the colon via cross-organ migration，colonize tumor tissues，and promote CRC initiation，progression，and therapeutic resistance. This review synthesizes evidence on the association between Fn and CRC，focusing on its promise as a biomarker for early detection，risk stratification，and disease monitoring，to provide novel insights for developing Fn-based strategies for the prevention，diagnosis，and management of CRC.

OBJECTIVE： To investigate current status and quality of domestic pharmacoeconomic literatures， and to provide reference for the standardization of pharmacoeconomic research. METHODS： Retrieved from CNKI， Wanfang， VIP and other database， the pharmacoeconomic literatures published from Jan. 2017 to May 2018 were collected. The qualities of literatures were evaluated with Guidelines for Quality Evaluation of Pharmacoeconomics Evaluation Reports （“PEERs” for short）. RESULTS： Totally 160 domestic pharmacoeconomic research literatures were included. The results of PEERs evaluation showed of which the coincidence rate was 32.5％ （52/160）. The literatureswhich were in full compliance （the report had a certain reference value） accounted for 1.3％ （2/160）， which were in basic compliance （the report had certain reference value after being revised） accounted for 31.3％（50/160），which were in non-conformity （the report did not had reference value） accounted for 67.5％（108/160）. Domestic pharmacoeconomic researches were of high quality in terms of research object， evaluation method and content，research purpose，  research design and design type， etc.； but the researches were of low quality in terms of research angle， incremental cost/incremental output analysis， sensitivity analysis and other aspects， and there was no explanation or unclear elaboration. CONCLUSIONS： The quality of domestic pharmacoeconomic research literatures are uneven， and their research quality needs to be further improved. It is recommended to standardize the evaluation of pharmacoeconomics， making the evaluation of pharmacoeconomics more scientific and objective.